CAMP4 Therapeutics Corporation Common Stock CAMP
$4.48
-0.22%
at last close
Financials (TTM)
- Revenue
- $4.22 million
- Net Income
- $-107,244,000
- Net Margin
- -2543.74%
- Return on Equity
- 15475.32%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- -406.58
- Price / Sales
- 66.83
Over the trailing twelve months, CAMP4 Therapeutics Corporation Common Stock generated revenue of $4.22 million and net income of $-107,244,000, a net margin of -2543.74%.
At the last closing price of $4.48, CAMP trades at 66.83 times sales, with a market capitalization of $281.76 million.
Key Stats
- Last Close
- $4.48
- Market Cap
- $281.76 million
- 52-Week Range
- $1.32 – $7.75
- Average Volume
- 270K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
